In an expansion of the company’s “An Accord for a Healthier World” program, which is aimed at increasing access to innovative treatments in some of the world’s poorest countries, Pfizer said it will now offer a total of 500 products.
A first-of-its-kind exploratory study, led by researchers from Yale School of Medicine, has found a single dose of the psychedelic psilocybin can reduce migraine frequency by 50 percent for a least two weeks.
In rural Oklahoma, a brand new medical school sits in the Cherokee Nation, training Nation members to become physicians at Nation clinics. Oklahoma State University College of Osteopathic Medicine at the Cherokee Nation is the first tribally associated medical school in the country.
The team from Australia’s Harry Perkins Institute of Medical Research found that a certain concentration of honeybee venom could be used to induce death in 100 percent of the cancer cells, while leaving healthy cells largely unharmed
A team of researchers from Michigan State University, University of Michigan and Dartmouth College is the first to demonstrate that placebos reduce brain markers of emotional distress even when people know they are taking one.